SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SARS and Avian Flu -- Ignore unavailable to you. Want to Upgrade?

To: Ilaine who wrote (719)5/6/2003 2:48:15 PM
From: JEB  Respond to of 4232
 
That's very true. Also, Zadaxin has been approved as an adjuvant (to be combined with another drug or vaccine) therapy for Influenza (specifically targeted for the coronavirus).

Sciclone conference call on SARS sales:
vcall.com

(give them some time to load the replay it just aired)



To: Ilaine who wrote (719)5/6/2003 6:39:01 PM
From: RealMuLan  Read Replies (2) | Respond to of 4232
 
>>SARS patients with pre-existing hepatitis B infections are more likely to have serious complications. <<

I have not seen any report on this. But WHO also speculated that AIDS patients are especially vulnerable for SARS, but the reality is just opposite, for whatever unknown reason.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News